dacarbazine and pf 3512676

dacarbazine has been researched along with pf 3512676 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Marshall, E; O'Day, S; Redman, B; Trefzer, U; van den Eertwegh, AJ; Wagner, S; Weber, JS; Zarour, H	1

Trials

1 trial(s) available for dacarbazine and pf 3512676

Article	Year
Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. Cancer, 2009, Sep-01, Volume: 115, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytokines; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Oligodeoxyribonucleotides; Skin Neoplasms; Survival Analysis; Treatment Outcome	2009

Article

Year

Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.

Cancer, 2009, Sep-01, Volume: 115, Issue:17

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytokines; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Oligodeoxyribonucleotides; Skin Neoplasms; Survival Analysis; Treatment Outcome

2009